Inventor · disambiguated record
Fabrice Chretien
Also filed as: CHRETIEN FABRICE · CHRETIEN FABRICE BRUNO
6 granted patents·6 pending applications·22 citations·filing 2011–2022
77Inventor score
Top patents by PatentIndex Score
12 records- 0189US10076113B2Methods for obtaining stem cellsPASTEUR INSTITUT·Filed 2016·Granted Sep 18, 2018·10 cites·24 claims
- 0285US9499792B2Methods for obtaining stem cellsCHRETIEN FABRICE·Filed 2011·Granted Nov 22, 2016·10 cites·13 claims
- 0377US10493046B25-hydroxytryptamine 1B receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiationPASTEUR INSTITUT·Filed 2016·Granted Dec 3, 2019·2 cites·21 claims
- 0463US11344515B25-hydroxytryptamine 1B receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiationPASTEUR INSTITUT·Filed 2019·Granted May 31, 2022·0 cites·27 claims
- 0562US2022233503A1Methods of treating sepsis with synaptic vesicle 2a and/or 2b binding chemical entitiesPASTEUR INSTITUT·Filed 2022·Application pending·0 cites
- 0657US2021330863A15-hydroxytryptamine 1b receptor-stimulating agent for enhancing in vivo engraftment potentialPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 0755US11013830B25-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potentialPASTEUR INSTITUT·Filed 2016·Granted May 25, 2021·0 cites·11 claims
- 0853US2020121644A1Methods of treating sepsis with synaptic vesicle 2a and/or 2b binding chemical entitiesPASTEUR INSTITUT·Filed 2017·Application pending·0 cites
- 0953US2024148749A1Mntbap and m(iii)n-substituted pyridylporphyrins(mnps)for use in reversing sepsis-induced microglial cells alterations and/or for treating sepsis or sepsis-associated encephalopathyPASTEUR INSTITUT·Filed 2022·Application pending·0 cites
- 1036US12250944B2High-fidelity long-term storage of biological materialCENTRE NAT RECH SCIENT·Filed 2018·Granted Mar 18, 2025·0 cites·19 claims
- 1131US2018303772A15-hydroxytryptamine 1b receptor-stimulating agent for the treatment of myocardial infarctionPASTEUR INSTITUT·Filed 2016·Application pending·0 cites
- 1231US2019290641A15-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repairPASTEUR INSTITUT·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabrice Chretien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →